207 related articles for article (PubMed ID: 35421740)
1. The introduction of fentanyl on the US-Mexico border: An ethnographic account triangulated with drug checking data from Tijuana.
Friedman J; Bourgois P; Godvin M; Chavez A; Pacheco L; Segovia LA; Beletsky L; Arredondo J
Int J Drug Policy; 2022 Jun; 104():103678. PubMed ID: 35421740
[TBL] [Abstract][Full Text] [Related]
2. Fentanyl, heroin, and methamphetamine-based counterfeit pills sold at tourist-oriented pharmacies in Mexico: An ethnographic and drug checking study.
Friedman J; Godvin M; Molina C; Romero R; Borquez A; Avra T; Goodman-Meza D; Strathdee S; Bourgois P; Shover CL
Drug Alcohol Depend; 2023 Aug; 249():110819. PubMed ID: 37348270
[TBL] [Abstract][Full Text] [Related]
3. Correlates of recent overdose among people who inject drugs in the San Diego/Tijuana border region.
Bailey K; Abramovitz D; Patterson TL; Harvey-Vera AY; Vera CF; Rangel MG; Friedman J; Davidson P; Bourgois P; Strathdee SA
Drug Alcohol Depend; 2022 Nov; 240():109644. PubMed ID: 36179507
[TBL] [Abstract][Full Text] [Related]
4. Being "hooked up" during a sharp increase in the availability of illicitly manufactured fentanyl: Adaptations of drug using practices among people who use drugs (PWUD) in New York City.
McKnight C; Des Jarlais DC
Int J Drug Policy; 2018 Oct; 60():82-88. PubMed ID: 30176422
[TBL] [Abstract][Full Text] [Related]
5. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.
Rouhani S; Park JN; Morales KB; Green TC; Sherman SG
Harm Reduct J; 2019 Jun; 16(1):39. PubMed ID: 31234942
[TBL] [Abstract][Full Text] [Related]
6. Fentanyl, Heroin, and Methamphetamine-Based Counterfeit Pills Sold at Tourist-Oriented Pharmacies in Mexico: An Ethnographic and Drug Checking Study.
Friedman J; Godvin M; Molina C; Romero R; Borquez A; Avra T; Goodman-Meza D; Strathdee S; Bourgois P; Shover CL
medRxiv; 2023 May; ():. PubMed ID: 36747647
[TBL] [Abstract][Full Text] [Related]
7. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
[TBL] [Abstract][Full Text] [Related]
8. Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis.
Friedman J; Montero F; Bourgois P; Wahbi R; Dye D; Goodman-Meza D; Shover C
Drug Alcohol Depend; 2022 Apr; 233():109380. PubMed ID: 35247724
[TBL] [Abstract][Full Text] [Related]
9. Fentanyl is used in Mexico's northern border: current challenges for drug health policies.
Fleiz C; Arredondo J; Chavez A; Pacheco L; Segovia LA; Villatoro JA; Cruz SL; Medina-Mora ME; de la Fuente JR
Addiction; 2020 Apr; 115(4):778-781. PubMed ID: 31837278
[TBL] [Abstract][Full Text] [Related]
10. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study.
Carroll JJ; Marshall BDL; Rich JD; Green TC
Int J Drug Policy; 2017 Aug; 46():136-145. PubMed ID: 28578864
[TBL] [Abstract][Full Text] [Related]
11. "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.
Shin SS; LaForge K; Stack E; Pope J; Leichtling G; Larsen JE; Leahy JM; Seaman A; Hoover D; Chisholm L; Blazes C; Baker R; Byers M; Branson K; Korthuis PT
Harm Reduct J; 2022 Jul; 19(1):76. PubMed ID: 35818072
[TBL] [Abstract][Full Text] [Related]
12. Investigating opioid preference to inform safe supply services: A cross sectional study.
Ferguson M; Parmar A; Papamihali K; Weng A; Lock K; Buxton JA
Int J Drug Policy; 2022 Mar; 101():103574. PubMed ID: 35007878
[TBL] [Abstract][Full Text] [Related]
13. Rapid Analysis of Drugs: A Pilot Surveillance System To Detect Changes in the Illicit Drug Supply To Guide Timely Harm Reduction Responses - Eight Syringe Services Programs, Maryland, November 2021-August 2022.
Russell E; Sisco E; Thomson A; Lopes J; Rybak M; Burnett M; Heilman D; Appley MG; Gladden RM
MMWR Morb Mortal Wkly Rep; 2023 Apr; 72(17):458-462. PubMed ID: 37104171
[TBL] [Abstract][Full Text] [Related]
14. Evaluating Technologies to Identify Fentanyl and Adulterants in Street Drug Paraphernalia: Qualitative Perspectives of Service Providers and Their Clientele.
Santelices C; Matsumoto A; Boulad M; Stopka TJ
Subst Use Misuse; 2023; 58(12):1528-1535. PubMed ID: 37424449
[No Abstract] [Full Text] [Related]
15. Prevalence of fentanyl in methamphetamine and cocaine samples collected by community-based drug checking services.
Wagner KD; Fiuty P; Page K; Tracy EC; Nocera M; Miller CW; Tarhuni LJ; Dasgupta N
Drug Alcohol Depend; 2023 Nov; 252():110985. PubMed ID: 37826988
[TBL] [Abstract][Full Text] [Related]
16. Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market.
Duhart Clarke SE; Kral AH; Zibbell JE
Int J Drug Policy; 2022 Jan; 99():103467. PubMed ID: 34662847
[TBL] [Abstract][Full Text] [Related]
17. The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogs.
Kim HK; Connors NJ; Mazer-Amirshahi ME
Expert Opin Drug Saf; 2019 Jun; 18(6):465-475. PubMed ID: 31033357
[TBL] [Abstract][Full Text] [Related]
18. Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users.
Swartz JA; Lieberman M; Jimenez AD; Mackesy-Amiti ME; Whitehead HD; Hayes KL; Taylor L; Prete E
Harm Reduct J; 2023 Jul; 20(1):87. PubMed ID: 37420196
[TBL] [Abstract][Full Text] [Related]
19. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States.
Peiper NC; Clarke SD; Vincent LB; Ciccarone D; Kral AH; Zibbell JE
Int J Drug Policy; 2019 Jan; 63():122-128. PubMed ID: 30292493
[TBL] [Abstract][Full Text] [Related]
20. The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings.
Bolinski RS; Walters S; Salisbury-Afshar E; Ouellet LJ; Jenkins WD; Almirol E; Van Ham B; Fletcher S; Johnson C; Schneider JA; Ompad D; Pho MT
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
